Navigation Links
Varian Medical Systems Launches OncoPeer, a Cloud-Based Resource for Sharing Clinical Information and Experience

PALO ALTO, Calif., May 11, 2015 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) today announced the launch of OncoPeer™, a cloud-based interactive resource for oncology professionals intended to help improve the efficiency, quality, and consistency of care in cancer clinics.  Varian customers can access OncoPeer 24-hours per day, to exchange knowledge and experience with other clinicians.

"Providing clinicians with resources that enable them to pool knowledge and learn from each other has become an important goal for us, as treatment centers seek ever more effective ways of implementing precise, non-invasive treatments like RapidArc® radiosurgery," said Kolleen Kennedy, president of Varian's Oncology Systems business.  "We developed OncoPeer as a tool to help our customers collaborate, find others who use Varian technology, and learn from one another."

Users of the OncoPeer cloud community will be able to initiate threaded discussions, form open or closed groups, share and comment about uploaded files, create events, monitor trending key words within the community, and sort information by keyword.  Varian will also use the tool to support communication between members of advisory boards that provide feedback on products and services. 

"We intend this to be a place for our customers to connect and share," said Sukhveer Singh, vice president and general manager of the Oncology Continuum Solutions business at Varian.   "Within the OncoPeer community, Varian customers will be able to set up their own groups to collaborate within or across institutions.  We anticipate that users will find different ways to use it.  Medical oncologists configuring the ARIA® oncology information system to support their clinical processes might reach out to colleagues who have already accomplished this for tips and advice.  A medical physicist might ask peers a question pertaining to quality assurance processes, or share specific procedures utilized in his or her clinic."

"We're excited about how the early adopters are already using the resource to help one another," said Sarah Gyatso, manager of the OncoPeer cloud community.  "Recently a community member posted a question to the nearly 600 users we had signed up so far, asking for tips when creating radiotherapy treatment plans for prostate cancer patients with bilateral hip replacements.  The user received a detailed answer from an experienced member, who offered specific and actionable advice.  This was a perfect example of the peer-to-peer knowledge exchange that OncoPeer is intended to support."

The OncoPeer community is being rolled out initially for access by customers in North America, the United Kingdom, Ireland, Australia and New Zealand; Varian will roll it out for users in other geographic areas starting in mid-June.  Varian's role is to supply and support the site technically, and monitor communications for adherence to guidelines.  It will not be used as a channel for company or promotional communications and must not include protected health information of individually identifiable patients.   

Varian will be holding an online seminar about Navigating OncoPeer on Tuesday, May 12, at 8 a.m. PDT.  Interested clinicians can find out more at this registration website.

About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, focuses energy on saving lives by equipping the world with advanced technology for fighting cancer and for X-ray imaging.  The company is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiation. The company provides comprehensive solutions for radiotherapy, radiosurgery, proton therapy and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is also a premier supplier of X-ray imaging components, including tubes, digital detectors, and image processing software and workstations for use in medical, scientific, and industrial settings, as well as for security and non-destructive testing.  Varian Medical Systems employs approximately 6,800 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world.  For more information, visit or follow us on Twitter.

Forward-Looking Statements
Except for historical information, this news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements concerning industry outlook, including growth drivers; the ability of the company's technology and products to treat cancer; and any statements using the terms "intend," "will," "anticipate," and "might," or similar statements are forward-looking statements that involve risks and uncertainties that could cause the company's actual results to differ materially from those anticipated. Such risks and uncertainties include the effect of global economic conditions; demand for the company's products; the company's ability to develop, commercialize, and deploy new products; the company's ability to meet legal and regulatory requirements; changes in the legal or regulatory environment; and the other risks listed from time to time in the company's filings with the Securities and Exchange Commission, which by this reference are incorporated herein. The company assumes no obligation to update or revise the forward-looking statements in this release because of new information, future events, or otherwise.

Press Contact
Meryl Ginsberg
Varian Medical Systems
+1 (650) 424-6444


SOURCE Varian Medical Systems
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Varian Medical Systems Receives FDA 510(k) Clearance of its Nexus DRF Digital X-Ray Imaging System
2. Preclinical and Phase 1 Data of VTX-2337 Presented at 2013 ASCO Annual Meeting Shows Early Activity in Ovarian Cancer
3. Emerging Targeted Therapies Offer Efficacy Advantages Over Currently Used Chemotherapies for Platinum-Resistant Advanced Ovarian Cancer
4. Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer
5. Varian Software Successfully Connected with Siemens Linear Accelerators
6. Supreme Court Ruling Today Allows DNATraits to Offer Low Cost BRCA Breast and Ovarian Cancer Gene Testing in U.S.
7. Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2013
8. The Majority of Surveyed Oncologists Prescribe Avastin Off-label to Their Ovarian Cancer Patients; However Approximately Half Encounter Access and Reimbursement Hurdles
9. Varian Medical Systems Schedules Investor Meeting at ASTRO in Atlanta
10. Varian Medical Systems Publishes 2013 Sustainability Report Outlining Environmental, Charitable, Safety and Health Access Achievements
11. CIVCOs Protura and Varian Integration Keeps Motion Management Clearly on Target at ASTRO 2013
Post Your Comments:
(Date:9/28/2017)... -- Cohen Veterans Bioscience and Early Signal Foundation announce ... home sensors for real-time monitoring of patients with trauma-related ... organization focused on disruptive health solutions for rare disorders ... to record and integrate behavioral, cognitive, physiological and contextual ... ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
(Date:9/18/2017)... , Pa. and KALAMAZOO, Mich. , ... Allentown, Penn. , and OptiMed Specialty Pharmacy of ... business partnership to offer a strategic hub service that ... Healthcare,s highly sought-after personal spirometer, Spiro PD 2.0, and ... A spirometer is a medical device used to ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... ... in post-acute health care, have expanded their existing home health joint venture through ... AccentCare has been operating a joint venture home health company with Asante, delivering ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. ... recently contributed a medical article to the newly revamped Cosmetic Town journal ... spotlights the hair transplant procedure known as Follicular Unit Extraction (FUE). ...
(Date:10/12/2017)... D.C. (PRWEB) , ... October 12, 2017 , ... Leading ... their peers in Washington, D.C., for the 49th Congress of the International Society ... ., Vice President of the Center for Cancer and Blood Disorders at ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and ... 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness will ... Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry Autograph ...
(Date:10/12/2017)... ... 2017 , ... In the United States, single-family home owners ... New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and California—the average is $7,000 ... property-tax rates, which contributes to the relatively lower cost of living in places ...
Breaking Medicine News(10 mins):